Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
COVID‐19 and ischemic stroke
Dimitrios Sagris, Aikaterini Papanikolaou, Alexandra Kvernland, Eleni Korompoki, Jennifer Frontera, Andrea B. Troxel, Maria Gavriatopoulou, Haralampos Milionis, Professor Gregory Lip, Patrik Michel, Shadi Yaghi, George Ntaios (2021). COVID‐19 and ischemic stroke. , 28(11), DOI: https://doi.org/10.1111/ene.15008.
Article34 days agoClinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre
Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Charalampos Filippatos, Vasiliki Spiliopoulou, Magdalini Migkou, Foteini Theodorakakou, N Kanellias, Evangelos Eleutherakis‐Papaiakovou, Despina Fotiou, E Katodritou, E Spanoudakis, Panagiotis Tsirigotis, N. Giannakoulas, Sosanna Delimpasi, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis (2026). Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre. , 208(3), DOI: https://doi.org/10.1111/bjh.70342.
Article33 days agoBelantamab Mafodotin plus Lenalidomide/Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma: Long-Term Efficacy and Safety Results from the Phase 1/2 BelaRd Study
Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Nikolaos Kanellias, Eirini Solia, Panagiotis Malandrakis, Vasiliki Spiliopoulou, Foteini Theodorakakou, Magdalini Migkou, Evangelos Eleutherakis Papaiakovou, Despina Fotiou, Giorgos Psarros, Efstathios Kastritis, Meletios A Dimopoulos (2025). Belantamab Mafodotin plus Lenalidomide/Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma: Long-Term Efficacy and Safety Results from the Phase 1/2 BelaRd Study. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)03784-x.
Article33 days agoPOSTER: MM-435 Sequential Whole-Body Magnetic Resonance Imaging for Evaluating Treatment Response in Patients With Newly Diagnosed Multiple Myeloma
Erasmia Boutakoglou, Ioannis Ntanasis-Stathopoulos, Maria Douka, Vassilis Koutoulidis, Maria Gavriatopoulou, Panos Malandrakis, Vasiliki Spiliopoulou, Charis Filippatos, Fenia Theodorakakou, Despina Fotiou, Magdalini Migkou, Nikos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Eirini Solia, Efstathios Kastritis, Evangelos Terpos, Lia A. Moulopoulos, Meletios A Dimopoulos (2025). POSTER: MM-435 Sequential Whole-Body Magnetic Resonance Imaging for Evaluating Treatment Response in Patients With Newly Diagnosed Multiple Myeloma. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)01260-1.
Article33 days agoMM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)02604-7.
Article33 days ago